☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Veyvondi
Insights+: EMA Marketing Authorization of New Drugs in October 2023
November 23, 2023
Baxalta Received CHMP Positive Opinion for Veyvondi for the treatment of Bleeding Episodes in patients with von Willebrand disease
October 12, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.